Market Cap : 13.56 B | Enterprise Value : 13.32 B | PE Ratio : | PB Ratio : 19.26 |
---|
NAS:NVAX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:NVAX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novavax's Accounts Payable for the three months ended in Dec. 2020 was $54.3 Mil. Novavax's Cost of Goods Sold for the three months ended in Dec. 2020 was $0.0 Mil.
During the past 13 years, Novavax's highest Days Payable was 314.37. The lowest was 0.00. And the median was 201.78.
Novavax's Days Payable stayed the same from Dec. 2019 (0.00) to Dec. 2020 (0.00). stayed the same
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Novavax's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Novavax's Days Payable for the fiscal year that ended in Dec. 2020 is calculated as
Days Payable | = | Accounts Payable | / | Cost of Goods Sold | * | Days in Period |
= | 54.332 | / | 0 | * | 365 | |
= |
Novavax's Days Payable for the quarter that ended in Dec. 2020 is calculated as:
Days Payable | = | Accounts Payable | / | Cost of Goods Sold | * | Days in Period |
= | 54.332 | / | 0 | * | 365 / 4 | |
= |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline